Publication
Missing prognostic value of soluble PD-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy - A CEPAC-TDM biomarker substudy.
Journal Paper/Review - Jan 1, 2024
Geiger Kimberly, Jörger Markus, Roessler Max, Hettwer Karina, Ritter Christoph, Simon Kirsten, Uhlig Steffen, Holdenrieder Stefan
Units
PubMed
Doi
Contact
Citation
Geiger K, Jörger M, Roessler M, Hettwer K, Ritter C, Simon K, Uhlig S, Holdenrieder S. Missing prognostic value of soluble PD-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy - A CEPAC-TDM biomarker substudy. Tumour Biol 2024; 46:S355-S367.
Type
Journal Paper/Review (English)
Journal
Tumour Biol 2024; 46
Publication Date
Jan 1, 2024
Issn Electronic
1423-0380
Pages
S355-S367
Brief description/objective
Programmed cell death receptors and ligands in cancer tissue samples are established companion diagnostics for immune checkpoint inhibitor (ICI) therapies.